Back

Side effects and major adverse cardiac events caused by fractional flow reserve measurement: a systematic review and meta-analysis of 12,215 patients

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Intravascular imaging / physiology: guiding PCI to improve outcomes Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Johannes Michael Altstidl

Friedrich Alexander University Erlangen Nuernberg, Erlangen (Germany)

5 More presentations in this session

Presentation thumbnail
Changes in high-sensitivity troponin according to optical characteristics of neointima and treatment modality of in-stent restenosis
Doctor N. Nano (Munich, DE)
Abstract Slides
Presentation thumbnail
Clinical relevance of impaired physiological assessment after percutaneous coronary intervention: a meta-analysis
Professor R. van Geuns (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Correlation of FFR measured after DES implantation with clinical parameters and long-term clinical outcome
Doctor B. Csanadi (Budapest, HU)
Abstract Slides
Presentation thumbnail
Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial
Doctor S. KAGEYAMA (Shizuoka, JP)
Abstract Slides
Presentation thumbnail
Pathological analysis of struts coverage after second- and third-generation drug-eluting stents implantation for duration of dual anti-platelets therapy; an autopsy study
Mr K. Aihara (Kanagawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Intravascular imaging / physiology: guiding PCI to improve outcomes

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Nuclear cardiology is best for risk assessment
thumbnail
Congress Presentation
Intracoronary imaging: from research tool to class IA in the Guidelines
thumbnail
Congress Presentation
Beyond the stenosis: physiological assessment in modern coronary artery disease management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources